GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

Clinical trial NCT05109793 · COMPLETED

Trial details

NCT number: NCT05109793
Sponsor: Azafaros B.V.
Status: COMPLETED
Study type: OBSERVATIONAL

GM1 Gangliosidosis Sandhoff Disease Tay-Sachs Disease

Start date: 2022-02-22
Primary completion: 2025-09-16
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.